Biological E was asked for more information
about Corbevax for children aged 5 to 12
Biological E, a Hyderabad-based pharmaceutical business, has sought for an Emergency Use Authorization (EUA) for its COVID-19 vaccine Corbevax for children aged 5 to 12.
Zydus would deliver goods to US firm
Sagent from its Gujarat factory
Zydus Lifesciences announced that it will deliver Caffeine Citrate Oral Solution from its Gujarat-based production plant to US-based Sagent Pharmaceuticals, Inc.
Bharat Bio partner Ocugen discontinue
Covaxin testing
USFDA informed the business that its phase 2/3 immuno-bridging and widening research for Covaxin (BBV152), OCU-002, had been placed on clinical hold.
Local pharmaceutical companies now
have easier access to launching goods
in Australia
The Therapeutic Goods Administration, Australia’s drug regulatory authority, has agreed to accelerate speedier and easier approvals for India’s generic pharmaceutical items that have already been licenced.
Novartis intends to lay off thousands of
employees
Novartis has confirmed that it intends to reduce its headcount as part of a restructuring initiative announced last week, but has declined to provide a figure for the cuts.
Amneal Pharmaceuticals receives FDA
approval for Alymsys
Amneal Pharmaceuticals has received FDA clearance for its biologics licence application for bevacizumab-maly, a biosimilar to Swiss manufacturer Roche Holding’s cancer medicine Avastin.
Biofrontera Inc. announces FDA approval of
Biofrontera Pharma GmbH
Biofrontera stated that the FDA has certified Biofrontera Pharma’s cGMP facility in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz.